Skip to content

Circ_0027446: a novel biomarker and therapeutic target to combat colorectal cancer and enhance immune response

Jul 2026 · Journal of Molecular Histology · Vol 57 · 0 citations · 29 references
Medicine

TL;DR

Higher circ_0027446 expression was associated with larger tumor size, lymph node metastasis, advanced TNM stage, and shorter overall survival, and may contribute to tumor progression and immune escape-related changes, at least partly through the miR-6882-3p/HOXB9 axis.

View source

Similar papers

Open access Aug 2026

CircRNA PVT1 promotes migration, invasion and glucose metabolism of thyroid cancer cells through modulating the miR-195-5p-PDK4 axis

In vivo, circPVT1 promoted tumor growth and lung metastasis, which were attenuated by co-expression of miR-195-5p, and molecular analysis of lung metastases confirmed the dysregulation of the circPVT1/miR-195-5p/PDK4 axis within metastatic lesions.

Huanli Hu, Yanan Lu, Yingchuan Sun et al. · 0 citations
Aug 2026

Hsa_circ_0001839 is associated with poor prognosis and promotes tumor progression in gastric cancer.

As an oncogenic circRNA, hsa_circ_0001839 is critically implicated in gastric cancer progression and unfavorable patient outcomes, underscoring its dual application as a promising prognostic biomarker and a potential therapeutic intervention target.

Zhengliang Li, Xiaojing Liu, Jun-Dong Wang et al. · 0 citations
Open access Jul 2026

MiR-4327 targets TP53 to promote cervical cancer cell proliferation

Cervical cancer is a leading cause of female malignancy worldwide. While microRNA-4327 (miR-4327) has been implicated as a potential oncogene, its functional role and molecular mechanisms in cervical cancer pathogenesis remain unclear. This study aimed to determine the oncogenic function of miR-4327 and elucidate its d...

Meilin Chen, Chenyang Chu, Feng-Xian Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.